Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs European In-Vitro Cancer Diagnostics Markets
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

European In-Vitro Cancer Diagnostics Markets

DateJun, 2000
Pages0
Price / format€3503 / Hard Copy
€3127 / Site License
€4257 / Enterprisewide

€3 101 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:


This report from Frost & Sullivan divides the in-vitro cancer diagnostics market into an in-depth analysis in each of the four segments - immunoassay, immuno-histochemistry, clinical chemistry and nucleic acid based. This report focuses specifically upon the markets in Germany, France, Italy, United Kingdom, Spain, Benelux, and Scandinavia. New technologies are emerging in the field of in-vitro cancer diagnostics. Tools that are used to diagnose, screen and monitor specific types of cancer may have a profound effect upon this industry. Nucleic acid base testing, based on polimerase chain reaction (PCR), and fluorescent in-situ hybridization (FISH) technologies are set to revolutionize the cancer diagnostic market by providing much of the revenue growth in the medium and long term. These novel techniques offer a higher level of specificity and sensitivity than traditional technologies, enabling earlier detection of cancer and enhanced follow-up testing. The launch of new chemosensitive assays, which establish whether or not patients are genetically compatible with cancer therapies, will create a new market in the field of in-vitro cancer diagnostic testing, states the author of the report.


The European in-vitro cancer diagnostics market has recently experienced declining revenues as a result of the consolidation of testing laboratories. This consolidation enhanced end-user purchasing power, leading to falling prices in the immunoassay and clinical chemistry markets, which deterred many new entrants from joining the market. Ten companies in this market now hold eighty-three percent of the market share. In light of this consolidation trend, small and medium-sized companies have been struggling to maintain the adequate level of research and development, spending what is necessary to continue to provide a broad range of testing parameters. Smaller firms are finding they must concentrate on niche marketing areas in order to avoid being forced out of the market altogether. However, opportunities still exist in this market because of the rising patient population and the development of new genetic markers. In addition, DNA amplification and FISH technologies provide new opportunities for companies to develop new, highly sensitive and specific testing parameters. This Frost & Sullivan report helps users keep a close watch on the competitive environment of the in-vitro cancer diagnostics markets, and offers the solutions needed to pull ahead of the competition.











Table of contents:
 - Introducing the Market Engineering Consulting Report

- The Market Engineering System

- Market Engineering Report Elements

- Strategic Benefits of Market Engineering for Readers of This Report

- Top Ten Benefits of a Market Engineering Consulting Report

- A Word of Caution

- Executive Summary

- Introduction to the European In-Vitro Cancer Diagnostics Market

- Summary of Major Findings

- Conclusions

- Industry Challenges and Research Methodology

- Identification of Challenges Facing the European In-Vitro Cancer Diagnostics Market

- Time Frame Analysis of Industry Challenge

- Frost & Sullivan's 12-Step Market Engineering Research Methodology

- Market Engineering Forecasting Methodology

- Market Engineering Research for the Total European In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Cancer Diagnostics Market

- Market Engineering Research for the German In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Research for the French In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Research for the Italian In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Research for the United Kingdom In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Research for the Spanish In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Research for the Benelux In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Research for the Scandinavian In-Vitro Cancer Diagnostics Market

- Forecasts of the Total Market

- Forecasts of the Immunoassay Market

- Forecasts of the Immunohistochemistry Market

- Forecasts of the Clinical Chemistry Market

- Forecasts of the Nucleic Acid-Based Market

- Market Engineering Strategy

- What Is Market Engineering Strategy?

- How to Improve the Market Engineering Strategy Development Process

- Market Engineering Strategic Recommendations

- Market Engineering Planning in the In-Vitro Cancer Diagnostics Industry

- Integrating Market Engineering into the Business Planning Process

- Using Market Engineering Planning to Support the Business Planning Process

- Implementation of Market Engineering

- Introduction and Summary

- How to Implement Market Engineering in a Company

- How to Make the Most of This Market Engineering Report

- Market Engineering Monitoring of the In-Vitro Cancer Diagnostics Industry

- The Purpose of Market Engineering Monitoring

- How to Design a Successful Monitoring Programme

- Top Ten Critical Elements of a Market Engineering Programme in the In-Vitro Cancer Diagnostics Industry

- Frost & Sullivan's Strategic Recommendations for Further Research

- Database of Key Industry Participants

- Market Participants

- Related Companies

- Associations




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com